The neuropeptide substance P/neurokinin-1 receptor system and diabetes: From mechanism to therapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The neuropeptide substance P/neurokinin-1 receptor system and diabetes: From mechanism to therapy.
- Published In:
- BioFactors (Oxford, England), 49(3), 534-559 (2023)
- Authors:
- Kokabi, Fariba, Ebrahimi, Safieh, Mirzavi, Farshad, Ghiasi Nooghabi, Nazanin, Hashemi, Seyedeh Fatemeh, Hashemy, Seyed Isaac
- Database ID:
- RPEP-07056
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07056APA
Kokabi, Fariba; Ebrahimi, Safieh; Mirzavi, Farshad; Ghiasi Nooghabi, Nazanin; Hashemi, Seyedeh Fatemeh; Hashemy, Seyed Isaac. (2023). The neuropeptide substance P/neurokinin-1 receptor system and diabetes: From mechanism to therapy.. BioFactors (Oxford, England), 49(3), 534-559. https://doi.org/10.1002/biof.1935
MLA
Kokabi, Fariba, et al. "The neuropeptide substance P/neurokinin-1 receptor system and diabetes: From mechanism to therapy.." BioFactors (Oxford, 2023. https://doi.org/10.1002/biof.1935
RethinkPeptides
RethinkPeptides Research Database. "The neuropeptide substance P/neurokinin-1 receptor system an..." RPEP-07056. Retrieved from https://rethinkpeptides.com/research/kokabi-2023-the-neuropeptide-substance-pneurokinin1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.